Ads
related to: pubmed universal phage displaycreative-biolabs.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Phage display is also a widely used method for in vitro protein evolution (also called protein engineering). As such, phage display is a useful tool in drug discovery. It is used for finding new ligands (enzyme inhibitors, receptor agonists and antagonists) to target proteins.
John McCafferty is a British scientist, one of the founders of Cambridge Antibody Technology alongside Sir Gregory Winter and David Chiswell. He is well known as one of the inventors of scFv antibody fragment phage display, [1] a technology that revolutionised the monoclonal antibody drug discovery.
C15orf62 is a protein which in humans is encoded by the C15orf62 gene. [5] The protein displays high levels of expression in the esophagus and skin of human tissue. [6] C15orf62 is a regulatory protein involved in mitochondrial function and cytoskeletal organization, playing roles in ribosomal biogenesis, Rho protein signal transduction, and protein turnover through ubiquitination. [7]
PubMed is a free database including primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics. The United States National Library of Medicine (NLM) at the National Institutes of Health maintains the database as part of the Entrez system of information retrieval.
The first step is to have phage display libraries prepared. This involves inserting foreign desired gene segments into a region of the bacteriophage genome, so that the peptide product will be displayed on the surface of the bacteriophage virion. The most often used are genes pIII or pVIII of bacteriophage M13. [5]
The 'Nuts and Bolts' of Phage Therapy. a special issue of the journal, Current Pharmaceutical Biotechnology, consisting of six articles on phage therapy, plus an editorial. Carnazza, S., Guglielmino, S. eds. 2010. Phage Display As a Tool for Synthetic Biology. Nova Science Publishers, Hauppauge, New York. ISBN 978-1-60876-987-2, Google Books
Cambridge Antibody Technology Group Plc, (commonly referred to as CAT) was a biotechnology company headquartered in Cambridge, England, United Kingdom.Its core focus was on antibody therapeutics, primarily using Phage Display and Ribosome Display technology.
The main academic full-text databases are open archives or link-resolution services, although others operate under different models such as mirroring or hybrid publishers. . Such services typically provide access to full text and full-text search, but also metadata about items for which no full text is availa
Ads
related to: pubmed universal phage displaycreative-biolabs.com has been visited by 10K+ users in the past month